Clinical trial NCT01304108: Improving Venous Thromboembolism Prophylaxis
Official title: Spreading and Improving DVT Prophylaxis at Mayo Clinic (DVT-P-Spread)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Venous Thromboembolism
Delivery of Health Care
Quality Improvement
Keywords: Venous Thromboembolism
Delivery of Health Care
Quality Improvement
Evidence-Based Practice
Lead sponsor: Mayo Clinic
Sponsor class: OTHER
First posted: 2011-02-25
Enrollment: 3000
Sex: ALL
Minimum age (years): 17
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for \&quot;spreading\&quot; to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.

Detailed description: Venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including our own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for \&quot;spreading\&quot; to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%. This began as a quality improvement project. The investigators have taken baseline measures of VTE-P rates in our hospitals, intervened with various electronic prompts to use appropriate VTE-P, and have and will re-measure VTE-P rates. The investigators intend to present and publish our methods and results so that lessons learned may be shared and applied elsewhere.

Eligibility criteria: Inclusion Criteria:

* Inpatients with age \> 17 years old

Exclusion Criteria:

* Outpatients
* Inpatients with age less than or equal to 17 years old

Primary outcomes:
measure: % of in patients with an appropriate VTE prophylaxis plan
timeFrame: Baseline to 1 month
Secondary outcomes:
measure: Clinically significant complications of VTE-P anticoagulant therapy
timeFrame: baseline to 1 month
Other outcomes:
Locations:
city: Rochester
country: United States
facility: Mayo Clinic in Rochester
state: Minnesota
Study officials:
affiliation: Mayo Clinic
name: Timothy Morgenthaler, MD
role: PRINCIPAL_INVESTIGATOR
References: